David A. Ricks, SVP and President, Lilly Bio-Meds at LILLY ELI & CO (LLY), sold 3,000 shares at $53.91 ($162K) on 2013-02-08, disclosed to the SEC on 2013-02-11.
Open-market sale of $162k LLY by SVP and President, Lilly Bio-Meds. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ADBE | BUY | 2025-01-30 | $999K | — | Filing → |
| ADBE | BUY | 2022-09-27 | $337K | — | Filing → |
| LLY | BUY | 2019-10-25 | $1.0M | — | Filing → |